Rteceived for publication18 October 1972 We examined the effect of experimental meningeal infection with a neuraminidaseproducing strain of Diplococcus pneumoniae on the N-acetylneuraminic acid (NANA) content of canine cerebral cortical gray matter. The Warren thiobarbituric acid assay for NANA was used. There was no significant difference between the free and bound NANA levels of the tissue from control animals and from those with meningitis. This finding suggests that the neurological impairment so frequent in clinical pneumococcal meningitis is not a result of the activity of this bacterial enzyme upon cortical glycolipids.
High imiortality in adults with cenitral nervous system (CNS) disease due to Diplococcus pneumoniae continues (12) despite uniform susceptibility of the organisms to penicillin G. Since D. pneumoniae is not known to produce a toxin, the search for a possible pathogenic role of other bacterial products in pneumococcal disease has begun. Neuraminidase (EC 3.2.1.18), a glycosidic enzyme produced by fresh clinical isolates of D. pneumoniae (3) , is one of these. Neuraminidases are produced by a number of microorganisms and by mammalian tissues (5, 9). All cleave a terminal N-acetylated neuraminic acid from an adjacent sugar. N-acetylneuraminic acid (NANA)-containing substrates are found as part of glycoproteins and mucolipids in cell membranes and in body fluids.
In the CNS, the cerebral gangliosides are potential substrates for neuraminidase. Gangliosides are NANA-containing, water-soluble glycosphingolipids, which make up a significant portion of neuronal cell processes (1) . Because pneumococci are rarely histologically seen directly invading the brain in meningitis, one might postulate that diffusion of bacterial cell products contributed to neuronal cell dysfunction. Inoculum. An encapsulated strain of type II D. pneumoniae, isolated from the CSF of a patient with meningitis, was used. The organisms were grown in 10% rabbit blood in Tryptose phosphate broth and frozen as 0.2-ml samples in 0.5 ml of rabbit blood. The inoculum for injection into test animals was 1 ml of an 18-h culture of stock bacteria in Tryptose phosphate broth diluited to contain approximately 101 organisms per ml. In control animals the inoculum was 1 ml of sterile isotonic saline. Neuraminidase production. The isolate of D. pneumoniae was inoculated into 100 ml of Tryptose phosphate broth and incubated at 37 C for 18 h. The organisms were centrifuged at 6,250 rpm for 15 min, the supernatant fluid was discarded, and the organisms were resuspended in 2 ml of distilled water. The suspension was frozen (-65 C) and thawed (20 C) twice and centrifuged at 13,500 rpm for 15 min. Protein content of the supernatant fluid was determined by the method of Lowry et al. (4) . Neuraminidase activity of the supernatant fluid was determined by incubation with N-acetylneuraminlactose in tris(hydroxymethyl)aminomethane-acetate buffer (final concentration, 0.1 M) at 37 C for 30 min. The liberated NANA was measured by the thiobarbituric acid method of Warren (11) . A unit of neuraminidase activity was defined as that amount of enzyme which will liberate 1 pmol of NANA from an excess of neuraminlactose in 1 min at 37 C (9). Infection. Under sodium pentobarbital anesthesia, the skull of a dog was exposed by a paramedian incision. A hole (1.5 mm) was drilled into the frontoparietal area, the dura was punctured, and the burr hole was plugged with bone wax. The inoculum was then injected through the wax and the wound was closed in layers. This technique was adapted from Petersdorf and Luttrell (8 10.724 In this experiment, neuraminidase may have been rapidly removed by increased cerebral circulation in the meningitic dogs and thus not available for diffusion. Differences in circulation and thus removal of the enzyme and its products may well be responsible for the variable results in CSF NANA levels in earlier human studies. The elevated CSF NANA levels in O'Toole's study may have resulted from bacterial enzyme activity upon NANA-containing substrates from the serum, the choroid plexus, and the ependyma rather than from cortical tissue.
